Company news
|
17 October 2022 Alkor Bio Company Ltd. has confirmed its compliance with International Standard ISO 13485:2016In October Alkor Bio Company Ltd. – Russian designer and manufacturer of ELISA, CLIA and PCR in vitro diagnostic kits and instruments - has been assessed for compliance with the International Standard ISO 13485:2016.
|
23 December 2021 Merry Christmas and Happy New Year!
|
23 December 2021 Correction of Postischemic Changes in the Microcirculation of Rat Cerebral Cortex with Mesenchymal Stem CellsAbstract---This study aims at examining how intravenous transplantation of human mesenchymal stem cells (MSCs) performed on the day of ischemia/reperfusion affects the vascular density and the reactivity of the pial arteries and tissue perfusion in the cerebral cortex 7, 14, and 21 days after ischemic exposure. The density of the entire microvascular network and arterial vessels in the pial membrane of the sensorimotor cortex of rats undergoing cerebral |
Group "Alcor Bio" was established in 2007 on the basis of "Alcor Bio, the national leader in the manufacture of diagnostic products based on enzyme immunoassay.
In 2002, the company Alkor Bio "was singled company" Trans-Technologies, which specializes in studying the biology of human stem cells. On the basis of experimental data specialists are developing new methods of treatment of various diseases using stem cells.
OOO "Diagnostic Centers Alkor Bio provides the population of St. Petersburg laboratory diagnostic services. Besides DC Alkor Bio "is a clinical testing ground for clinical validation of diagnostic products manufactured by Company Alkor Bio.